Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
Date:3/3/2010

addition to, and not as a substitute for, or as superior to, financial measures prepared in accordance with GAAP. A reconciliation of the Company's non-GAAP adjusted financial measures to the corresponding GAAP financial measures, and an explanation of the Company's use of these non-GAAP adjusted financial measures and of the excluded items, are included in the appendix to this press release. - Adjusted EBITDA (earnings before interest, taxes, depreciation and amortization, adjusted to exclude certain non-cash and non-recurring items) was $6.9 million. - Adjusted revenue was $63.5 million. - Adjusted costs of goods sold was $28.4 million. - Adjusted research and development expenses were $5.6 million. - Adjusted selling, general and administrative expenses were $21.2 million. - Adjusted net loss and adjusted net loss per share for the quarter were $4.7 million and $0.06, respectively.

Fourth Quarter Highlights

Proprietary Medical Products. Our Proprietary Medical Products are marketed and sold by our two direct sales groups. We believe certain of these product lines contain technological advantages that have the potential for more substantial revenue growth potential as compared to our overall product portfolio. Our most significant commercial Proprietary Medical Products are our Quill(TM) SRS wound closure product line, Skater(TM) line of drainage catheters, Option(TM) Inferior Vena Cava Filter, HemoStream(TM) chronic d
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Angiotech Pharmaceuticals Announces Conference Call and Webcast
2. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
3. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
4. Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil
5. Angiotechs Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
8. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
9. Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
10. Angiotech Pharmaceuticals, Inc. announces conference call and webcast
11. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... 23, 2014 This is a ... of the Phenolic Resin industry in Global and ... industry, including definitions, applications and industry chain structure. ... are provided with a focus on history, developments, ... comparison between the international and Chinese situation is ...
(Date:9/23/2014)... de Reuil, France (PRWEB) September 23, 2014 ... to protection of laboratory personnel since 1968 and Burdinola, ... the development of a new filtered fume hood. ... above their laboratory fume hood, Burdinola will now offer ... for filtering a wide range of chemicals, best-in-class detection ...
(Date:9/23/2014)... Proove Biosciences , the commercial and research ... the association between specific genes and patients’ predisposition to ... Health Congress’ 27th Annual Scientific Program in Orlando, ... of ‘Embracing Change.’ Mental health, and healthcare as a ... challenges presented by the Affordable Care Act to the ...
(Date:9/23/2014)... Sept. 23, 2014 Research and ... "Proteomics Markets for Research and IVD Applications (Mass ... report to their offering. This ... applications, both in their research use and in ... the study of the structure and function of ...
Breaking Biology Technology:Phenolic Resin Industry (International, China) Development Policy and Plan Now Available at ReportsnReports.com 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 2Proove Biosciences Will Be Exhibiting New Genetic Research at the 27th Annual US Psych Congress Scientific Program 3Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 2Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 3Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays, Other Technologies) 4
... The power to edit genes is as revolutionary, immediately ... Gutenberg,s printing press. And like Gutenberg,s invention, most DNA ... brilliant technology in its infancy. Now, Harvard researchers developing ... processing have rewritten the genome of living cells using ...
... Neogen Corporation (NASDAQ: NEOG ) announces ... , Tuesday, July 26, 2011 @ 11:00 ETWhere: , ... -- Simply log on to the web at the ... Corporation, +1-800-234-5333If you are unable to participate during the ...
... time that the hormone leptin acts in the brain to ... mystery. Now, new research published by Cell Press in the ... neurobiological mechanisms that may underlie the antiobesity effects of leptin. ... cells and acts at its receptor in the brain to ...
Cached Biology Technology:Editing the genome 2Editing the genome 3Modulation of inhibitory output is key function of antiobesity hormone 2
(Date:9/23/2014)... more carbon than the atmosphere and small changes ... effect on atmospheric greenhouse gas concentrations. A new ... concludes that climate warming does not accelerate ... storage, despite increases in ecosystem productivity. , ... Ecologist Dr. Christian Giardina, with the agency,s Institute ...
(Date:9/23/2014)... funds to support the next phase of its Tissue ... predicting drug safety and effectiveness. Researchers will collaborate over ... and combine them into an integrated system that can ... by the National Center for Advancing Translational Sciences (NCATS), ... in 2014 with additional support over the remaining two ...
(Date:9/23/2014)... tissues during the healing process, cells must be ... scientists believed this communication happened primarily through chemical ... the University of Pittsburgh have found that another ... not more crucial. The findings, published in this ... National Academy of Sciences , could lead to ...
Breaking Biology News(10 mins):Study helps assess impact of temperature on belowground soil decomposition 2NIH funds next phase of Tissue Chip for Drug Screening program 2NIH funds next phase of Tissue Chip for Drug Screening program 3NIH funds next phase of Tissue Chip for Drug Screening program 4The mechanics of tissue growth 2
... 20 years have suggested (though not unequivocally,confirmed) that semen ... sperm counts and,reduced sperm motility.(1) The explanations have been ... and to male smoking. Now, a new study,based on ... study cohorts, suggests that,exposure to several factors in utero ...
... with thinner roots can grow deeper, a trait which could ... New research, to be presented at the Society for Experimental ... have fewer cortical cells in the outer layer of their ... A research team headed by Prof Jonathan Lynch at the ...
... in Antarctica, is so dark, deep and cold that scientists ... place where nothing could live. However, work by Dr. ... sciences, and his colleagues has revealed a surprising variety of ... environments. A paper published June 26 in PLOS ONE ...
Cached Biology News:Early life and in utero factors found to influence testicular function in adulthood 2Early life and in utero factors found to influence testicular function in adulthood 3In subglacial lake, surprising life goes on 2In subglacial lake, surprising life goes on 3In subglacial lake, surprising life goes on 4In subglacial lake, surprising life goes on 5
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/L; 1 tube of 1, 000 units enzyme/tube w/Buffer II and MgCl2...
... - 5 units/µL ,• High specific activity ... Leaves an 'A' overhang ,• Processes ... very high activity in primer extension and ... quality of the enzyme, each lot has ...
Recombinant DNA polymerase from Thermus aquaticus expressed in E. coli; 5 units/uL; 25 tubes of 1, 000 units enzyme/tube w/ Buffer I...
... Gold® DNA Polymerase is a chemically modified ... chemical moiety is attached to the enzyme, ... the first ramp of thermal cycling (when ... temperatures), the enzyme is inactive. The result ...
Biology Products: